Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
12 Patents
#272 in Sunnyvale, CA
#6,072 in California
#25,614 in US
#48,276 in the World
Revascular Therapeutics, Inc.
Forward Citations = 1,451
9 inventors:
Sunnyvale, CA, United States of America
Revascular Therapeutics, Inc.
Calculating rank
% Expired Patents = 75.0
Forward Citations = 1,451
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Gerardo V Noriega (8 out of 12 patents)
Rudolfo Sudaria (8 out of 10 patents)
Victor Chechelski (8 out of 13 patents)
4. Mike Carley (2 out of 2 patents)
5. Michael T Carley (1 out of 40 patents)
6. Thomas J Palermo (1 out of 54 patents)
7. Nestor Aganon (1 out of 14 patents)
8. Christopher Huynh (1 out of 1 patent)
9. Sudaria Rudolfo (1 out of 1 patent)
12 patents:
1. 9254143 - Guidewire for crossing occlusions or stenoses having a shapeable distal end (2016-02-09),
Company Overview
Revascular Therapeutics, Inc. is a biotechnology company based in Sunnyvale, California, focused on developing innovative therapies for cardiovascular diseases. The company specializes in advanced revascularization techniques aimed at restoring blood flow and improving heart function. Through its research and development efforts, Revascular Therapeutics is dedicated to addressing unmet medical needs in the treatment of ischemic conditions, leveraging cutting-edge technology to enhance patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Revascular Therapeutics, Inc.. Retrieved from https://idiyas.com/company/revascular-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]